Expert Review of Anticancer Therapy, Volume 18, Issue 2 (2018)

Browse this journal
Sample our Medicine, Dentistry, Nursing & Allied Health journals, sign in here to start your FREE access for 14 days

Expert Review of Anticancer Therapy, Volume 18, Issue 2 (2018)

See all volumes and issues
Vol 24, 2024 Vol 23, 2023 Vol 22, 2022 Vol 21, 2021 Vol 20, 2020 Vol 19, 2019 Volume 18, 2018 Vol 17, 2017 Vol 16, 2016 Vol 15, 2015 Vol 14, 2014 Vol 13, 2013 Vol 12, 2012 Vol 11, 2011 Vol 10, 2010 Vol 9, 2009 Vol 8, 2008 Vol 7, 2007 Vol 6, 2006 Vol 5, 2005 Vol 4, 2004 Vol 3, 2003 Vol 2, 2002 Vol 1, 2001
Download citations Download PDFs Download issue

Drug Profile

Article
Pembrolizumab for the treatment of bladder cancer
Nora Sundahl, Sylvie Rottey, Daan De Maeseneer & Piet Ost
Pages: 107-114
Published online: 29 Dec 2017
AbstractforPembrolizumab for the treatment of bladder cancer | Full Text | References | PDF (594.5 KB)
  • 622 Views
  • 11 CrossRef citations
  • 0Altmetric

Special Report

Article
Recent advances in fertility preservation and counseling for female cancer patients
Marie-Madeleine Dolmans
Pages: 115-120
Published online: 15 Dec 2017
AbstractforRecent advances in fertility preservation and counseling for female cancer patients | Full Text | References | PDF (602.4 KB)
  • 429 Views
  • 37 CrossRef citations
  • 0Altmetric

Review

Review
How to use neoadjuvant medical treatment to maximize surgery in melanoma
Teresa Amaral, Ioanna Tampouri & Claus Garbe
Pages: 121-130
Published online: 03 Jan 2018
AbstractforHow to use neoadjuvant medical treatment to maximize surgery in melanoma | Full Text | References | PDF (760.7 KB)
  • 289 Views
  • 6 CrossRef citations
  • 0Altmetric
Review
The evolution into personalized therapies in pancreatic ductal adenocarcinoma: challenges and opportunities
Anteneh A. Tesfaye, Mandana Kamgar, Asfar Azmi & Philip A. Philip
Pages: 131-148
Published online: 19 Dec 2017
AbstractforThe evolution into personalized therapies in pancreatic ductal adenocarcinoma: challenges and opportunities | Full Text | References | PDF (1.4 MB)
  • 308 Views
  • 27 CrossRef citations
  • 0Altmetric
Review
Current and future immunotherapies for thyroid cancer
Alessandro Antonelli, Silvia Martina Ferrari & Poupak Fallahi
Pages: 149-159
Published online: 22 Dec 2017
AbstractforCurrent and future immunotherapies for thyroid cancer | Full Text | References | PDF (835.3 KB)
  • 1595 Views
  • 40 CrossRef citations
  • 0Altmetric
Review
The development of PARP as a successful target for cancer therapy
Roberto Ferrara, Francesca Simionato, Chiara Ciccarese, Elisabetta Grego, Sara Cingarlini, Roberto Iacovelli, Emilio Bria, Giampaolo Tortora & Davide Melisi
Pages: 161-175
Published online: 26 Dec 2017
AbstractforThe development of PARP as a successful target for cancer therapy | Full Text | References | PDF (1.4 MB)
  • 714 Views
  • 15 CrossRef citations
  • 0Altmetric
Review
Peritoneal dissemination of ovarian cancer: role of MUC16-mesothelin interaction and implications for treatment
Ricardo Coelho, Lara Marcos-Silva, Sara Ricardo, Filipa Ponte, Antonia Costa, Jose Manuel Lopes & Leonor David
Pages: 177-186
Published online: 21 Dec 2017
AbstractforPeritoneal dissemination of ovarian cancer: role of MUC16-mesothelin interaction and implications for treatment | Full Text | References | PDF (954.4 KB)
  • 921 Views
  • 23 CrossRef citations
  • 0Altmetric

Original Research

Article
Challenging a dogma: five-year survival does not equal cure in all colorectal cancer patients
Omar Abdel-Rahman
Pages: 187-192
Published online: 26 Nov 2017
AbstractforChallenging a dogma: five-year survival does not equal cure in all colorectal cancer patients | Full Text | References | PDF (737.3 KB)
  • 144 Views
  • 11 CrossRef citations
  • 0Altmetric
Article
Toxicity profile characteristics of novel androgen-deprivation therapy agents in patients with prostate cancer: a meta-analysis
Jianhong Zhu, Rifang Liao, Chen Su, Dan Liang, Junyan Wu, Kaifeng Qiu & Jianfang Li
Pages: 193-198
Published online: 26 Dec 2017
AbstractforToxicity profile characteristics of novel androgen-deprivation therapy agents in patients with prostate cancer: a meta-analysis | Full Text | References | PDF (1 MB) | Supplemental
  • 400 Views
  • 23 CrossRef citations
  • 0Altmetric

Explore articles

Explore the most recently published articles

BEVACIZUMAB-CONTAINING TREATMENT for RELAPSED or REFRACTORY WILMS TUMOR
Sarah Al-Jilaihawi et al.
Review Article | Published online: 17 Jul 2024
Elevated DKK1 expression: a promising prognostic biomarker and therapeutic target in head and neck squamous cell carcinoma
Waseem Jerjes
Letter to the Editor | Published online: 15 Jul 2024
Free Access
The new life of ibrutinib therapy in CLL: enhancing personalized approaches
Stefano Molica et al.
Editorial | Published online: 15 Jul 2024
Free Access
Immune-related adverse events associated with Mogamulizumab: a comprehensive review of the literature
Genevieve S. Silva et al.
Review Article | Published online: 11 Jul 2024
View all latest articles